AtriCure PE Ratio 2010-2024 | ATRC

Current and historical p/e ratio for AtriCure (ATRC) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. AtriCure PE ratio as of March 31, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

AtriCure PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-03-28 31.83 0.00
2024-12-31 30.56 $-0.95 0.00
2024-09-30 28.04 $-0.83 0.00
2024-06-30 22.77 $-0.86 0.00
2024-03-31 30.42 $-0.80 0.00
2023-12-31 35.69 $-0.66 0.00
2023-09-30 43.80 $-0.54 0.00
2023-06-30 49.36 $-0.61 0.00
2023-03-31 41.45 $-0.82 0.00
2022-12-31 44.38 $-1.01 0.00
2022-09-30 39.10 $-1.22 0.00
2022-06-30 40.86 $1.16 35.22
2022-03-31 65.67 $1.12 58.63
2021-12-31 69.53 $1.07 64.98
2021-09-30 69.55 $0.95 73.21
2021-06-30 79.33 $-1.27 0.00
2021-03-31 65.52 $-1.11 0.00
2020-12-31 55.67 $-1.15 0.00
2020-09-30 39.90 $-1.15 0.00
2020-06-30 44.95 $-1.29 0.00
2020-03-31 33.59 $-1.20 0.00
2019-12-31 32.51 $-0.93 0.00
2019-09-30 24.94 $-0.60 0.00
2019-06-30 29.84 $-0.57 0.00
2019-03-31 26.79 $-0.47 0.00
2018-12-31 30.60 $-0.63 0.00
2018-09-30 35.03 $-0.62 0.00
2018-06-30 27.05 $-0.62 0.00
2018-03-31 20.52 $-0.82 0.00
2017-12-31 18.24 $-0.83 0.00
2017-09-30 22.37 $-1.02 0.00
2017-06-30 24.25 $-1.01 0.00
2017-03-31 19.15 $-1.06 0.00
2016-12-31 19.57 $-1.05 0.00
2016-09-30 15.82 $-1.14 0.00
2016-06-30 14.13 $-1.15 0.00
2016-03-31 16.83 $-1.07 0.00
2015-12-31 22.44 $-0.95 0.00
2015-09-30 21.91 $-0.79 0.00
2015-06-30 24.64 $-0.59 0.00
2015-03-31 20.49 $-0.51 0.00
2014-12-31 19.96 $-0.63 0.00
2014-09-30 14.72 $-0.67 0.00
2014-06-30 18.38 $-0.78 0.00
2014-03-31 18.81 $-0.77 0.00
2013-12-31 18.68 $-0.56 0.00
2013-09-30 10.98 $-0.44 0.00
2013-06-30 9.50 $-0.47 0.00
2013-03-31 7.92 $-0.46 0.00
2012-12-31 6.90 $-0.46 0.00
2012-09-30 7.44 $-0.47 0.00
2012-06-30 9.61 $-0.38 0.00
2012-03-31 9.95 $-0.36 0.00
2011-12-31 11.10 $-0.34 0.00
2011-09-30 9.74 $-0.21 0.00
2011-06-30 12.90 $-0.21 0.00
2011-03-31 11.38 $-0.20 0.00
2010-12-31 10.27 $-0.25 0.00
2010-09-30 7.87 $-0.41 0.00
2010-06-30 6.65 $-0.66 0.00
2010-03-31 5.89 $-0.71 0.00
2009-12-31 6.04 $-1.14 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.577B $0.465B
AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.058B 28.41
Boston Scientific (BSX) United States $149.209B 40.19
Stryker (SYK) United States $142.084B 30.54
EssilorLuxottica (ESLOY) France $131.854B 0.00
Medtronic (MDT) Ireland $115.249B 16.83
Haleon (HLN) United Kingdom $46.488B 26.39
Lonza Group Ag (LZAGY) Switzerland $44.527B 0.00
GE HealthCare Technologies (GEHC) United States $36.909B 17.98
Agilent Technologies (A) United States $33.351B 22.03
ResMed (RMD) United States $32.876B 25.32
Terumo (TRUMY) Japan $27.805B 39.54
Koninklijke Philips (PHG) Netherlands $23.874B 17.05
Zimmer Biomet Holdings (ZBH) United States $22.530B 14.15
Insulet (PODD) United States $18.442B 78.86
Baxter (BAX) United States $17.557B 12.63
Sunny Optical Technology (SNPTF) China $12.864B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $12.403B 0.00
Demant (WILYY) Denmark $8.048B 0.00
Bio-Rad Laboratories (BIO) United States $6.822B 23.62
Lantheus Holdings (LNTH) United States $6.684B 16.43
Prestige Consumer Healthcare (PBH) United States $4.259B 20.32
Perrigo (PRGO) Ireland $3.826B 10.95
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.405B 29.11
Haemonetics (HAE) United States $3.193B 15.02
Envista Holdings (NVST) United States $2.972B 23.64
QuidelOrtho (QDEL) United States $2.359B 19.76
GN Store Nord (GNNDY) Denmark $2.336B 15.74
LeMaitre Vascular (LMAT) United States $1.893B 43.25
Neogen (NEOG) United States $1.881B 21.67
AdaptHealth (AHCO) United States $1.462B 14.08
Kestra Medical Technologies (KMTS) $1.234B 0.00
InMode (INMD) Israel $1.234B 10.31
Green Thumb Industries (GTBIF) United States $1.233B 19.37
BioLife Solutions (BLFS) United States $1.073B 0.00
Phibro Animal Health (PAHC) United States $0.865B 13.27
Evolus (EOLS) United States $0.765B 0.00
Owens & Minor (OMI) United States $0.698B 5.94
CeriBell (CBLL) United States $0.689B 0.00
Curaleaf Holdings (CURLF) Canada $0.601B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.562B 0.00
Valneva SE (VALN) France $0.545B 0.00
VAREX IMAGING (VREX) United States $0.478B 20.71
Omeros (OMER) United States $0.476B 0.00
Surmodics (SRDX) United States $0.436B 0.00
Capricor Therapeutics (CAPR) United States $0.433B 0.00
SNDL (SNDL) Canada $0.371B 0.00
Cresco Labs (CRLBF) United States $0.354B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
Sanuwave Health (SNWV) United States $0.302B 0.00
ZimVie (ZIMV) United States $0.301B 18.00
Viemed Healthcare (VMD) United States $0.288B 26.00
Sanara MedTech (SMTI) United States $0.275B 0.00
Cerus (CERS) United States $0.258B 0.00
Quanterix (QTRX) United States $0.252B 0.00
OraSure Technologies (OSUR) United States $0.252B 0.00
Aurora Cannabis (ACB) Canada $0.247B 43.90
Verano Holdings (VRNOF) United States $0.233B 0.00
Utah Medical Products (UTMD) United States $0.184B 14.19
Biote (BTMD) United States $0.182B 4.16
Brainsway (BWAY) Israel $0.178B 55.71
TriSalus Life Sciences (TLSI) United States $0.168B 0.00
High Tide (HITI) Canada $0.153B 0.00
Canopy Growth (CGC) Canada $0.144B 0.00
TerrAscend (TSNDF) Canada $0.140B 0.00
Organigram Holdings (OGI) Canada $0.128B 0.00
Jin Medical (ZJYL) China $0.116B 0.00
FitLife Brands (FTLF) United States $0.112B 13.99
Quipt Home Medical (QIPT) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Fonar (FONR) United States $0.087B 12.18
MacroGenics (MGNX) United States $0.080B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.067B 24.44
United Health Products (UEEC) United States $0.066B 0.00
Exagen (XGN) United States $0.064B 0.00
InterCure (INCR) Israel $0.064B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
Modular Medical (MODD) United States $0.044B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
United-Guardian (UG) United States $0.041B 12.66
Rockwell Medical (RMTI) United States $0.038B 56.50
Safety Shot (SHOT) United States $0.027B 0.00
INLIF (INLF) $0.021B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Flora Growth (FLGC) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.003B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00